ArticleMicrobial cell factories2025
Repurposing the Sb(III)-specific efflux and sequestration system (ant operon) to mitigate antimonite cross-talk in ArsR-based bacterial arsenite sensors.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enzyme-cascade-amplified colorimetric biosensing platform for sub-nanomolar methylmercury in environmental waters.RSC advances · 2026Article
- Systematic evaluation of pigment-based whole-cell lead biosensors: challenges in genetic circuit engineering and critical considerations for background noise control.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundArsR-based whole-cell biosensors offer sensitive colorimetric detection of arsenite [As(III)], yet their broad reactivity toward Group 15 metalloids-especially antimonite [Sb(III)]-limits field specificity. The recently identified ant operon from Comamonas testosteroni JL40 confers Sb(III)-selective resistance via the efflux ATPase AntA, the metallochaperone AntC, and the regulator AntR, providing genetic parts to suppress Sb(III) cross-talk.
resultsWe systematically introduced antA, antC, and three antR homologs into an ArsR regulator coupled with a deoxyviolacein reporter chassis (pJ23119-K12). Co-expression of AntA and AntC under a moderate constitutive promoter (PceuR) shifted the Sb(III) limit of detection (LOD) from 0.073 µM to 0.586 µM, with a modest increase in the As(III) LOD to 0.018 µM. Subsequent integration of AntR1 not only maintained the As(III) LOD at 0.018 µM but also unexpectedly amplified the As(III) signal, extending the linear range to 36 nM-37.5 µM (R² = 0.991). It suggests that AntR1 may modulate the transcriptional circuitry via cross-regulation, warranting further mechanistic inquiry. The modified biosensor TOP10/pJ23119-antACR1 exhibited high selectivity for As(III) over divalent metals (Cd, Pb, Cu, Hg, Mn, Mg) and tolerated Sb(III) up to 1 µM. Performance was retained in 90% freshwater and 50% seawater matrices, enabling accurate quantification of 0-2.5 µM As(III) in deionized, tap, surface, and marine samples.
conclusionBy coupling Sb(III)-specific ant efflux/sequestration components with an ArsR-based sensing module, we developed a portable, low-cost biosensor that overcomes longstanding As(III)/Sb(III) cross-reactivity and performs robustly in complex environmental waters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.